These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tigecycline: a review of a new glycylcycline antibiotic. Scheinfeld N J Dermatolog Treat; 2005; 16(4):207-12. PubMed ID: 16249141 [TBL] [Abstract][Full Text] [Related]
23. A practice-based observational study identifying factors associated with the use of high-dose tigecycline in the treatment of secondary peritonitis in severely ill patients. Maseda E; Suárez-de-la-Rica A; Anillo V; Salgado P; Tamayo E; García-Bernedo CA; Ramasco F; Villagrán MJ; López-Tofiño A; Giménez MJ; Granizo JJ; Hernández-Gancedo C; Aguilar L; Gilsanz F Rev Esp Quimioter; 2015 Feb; 28(1):47-53. PubMed ID: 25690145 [TBL] [Abstract][Full Text] [Related]
24. Successful treatment of Stenotrophomonas maltophilia soft tissue infection with tigecycline: a case report. Belvisi V; Fabietti P; Del Borgo C; Marocco R; DI Vincenzo E; Soscia F; Mastroianni CM J Chemother; 2009 Jun; 21(3):367-8. PubMed ID: 19567363 [No Abstract] [Full Text] [Related]
26. Efficacy of tigecycline for the treatment of complicated intra-abdominal infections in real-life clinical practice from five European observational studies. Eckmann C; Montravers P; Bassetti M; Bodmann KF; Heizmann WR; Sánchez García M; Guirao X; Capparella MR; Simoneau D; Dupont H J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii25-35. PubMed ID: 23772043 [TBL] [Abstract][Full Text] [Related]
27. Tigecycline: the answer to beta-lactam and fluoroquinolone resistance? Fraise AP J Infect; 2006 Nov; 53(5):293-300. PubMed ID: 16876253 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of Tigecycline Efficacy and Post-Discharge Outcomes in a Clinical Practice Population with Complicated Intra-Abdominal Infection: A Propensity Score-Matched Analysis. Solomkin J; Mullins CD; Quintana A; Eckmann C; Shelbaya A; Ernst FR; Krukas MR; Reisman A Surg Infect (Larchmt); 2016 Aug; 17(4):402-11. PubMed ID: 26981640 [TBL] [Abstract][Full Text] [Related]
30. Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections. Sader HS; Mallick R; Kuznik A; Fritsche TR; Jones RN Int J Antimicrob Agents; 2007 Dec; 30(6):514-20. PubMed ID: 17959359 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of tigecycline monotherapy compared with vancomycin-aztreonam in the treatment of complicated skin and skin structure infections in patients from India and Taiwan. Chuang YC; Chang CM; Aradhya S; Nagari B; Pai V; Dartois N; Jouve S; Cooper A J Microbiol Immunol Infect; 2011 Apr; 44(2):116-24. PubMed ID: 21439514 [TBL] [Abstract][Full Text] [Related]
33. Tigecycline-induced acute pancreatitis: case report and literature review. Hung WY; Kogelman L; Volpe G; Iafrati M; Davidson L Int J Antimicrob Agents; 2009 Nov; 34(5):486-9. PubMed ID: 19540093 [TBL] [Abstract][Full Text] [Related]
34. Methicillin-resistant Staphylococcus aureus infection epidemiology and clinical response from tigecycline soft tissue infection trials. Puzniak LA; Quintana A; Wible M; Babinchak T; McGovern PC Diagn Microbiol Infect Dis; 2014 Jun; 79(2):261-5. PubMed ID: 24725736 [TBL] [Abstract][Full Text] [Related]
35. Skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus: role of tigecycline. Curcio D Clin Infect Dis; 2011 Jun; 52(12):1468-9. PubMed ID: 21498390 [No Abstract] [Full Text] [Related]
36. Treatment options for skin and soft tissue infections: 'oldies but goldies'. Unal S Int J Antimicrob Agents; 2009 Jul; 34 Suppl 1():S20-3. PubMed ID: 19560671 [TBL] [Abstract][Full Text] [Related]